Revascularization of AMI Patients Persists Despite No Demonstrated Benefit
He said the U.S. "must heed the call to professional responsibility aimed at the elimination of tests and treatments that do not result in any benefit for our patients, and for which the net effects will be added costs, waste, and possible harm."
Hochman said that for now, physicians should become more diligent about doing what's in the best interests of patients. "It's incumbent on them to take it upon themselves to stop doing procedures with no demonstrated benefit so that we can bring down healthcare costs before some expert body, like a health insurance company says we're not going to reimburse for it.
- CEO Exchange: Preparing for Population Health
- Advocate, NorthShore Deal Would Create 16-Hospital System
- Better HCAHPS Scores Protect Revenue
- Narrow Networks Cut Costs, Not Quality, Economists Say
- 3 Strategies for Retaining Millennial Employees
- Power of price: In South FL and the nation, healthcare costs often are shrouded in secrecy
- Hospital mergers may lead to higher prices
- Healthcare data of 1 million NJ patients compromised since 2009
- 'Early Offer' Malpractice Programs May Spur Reform